| Stage | LLY | % of rev | AMRX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $796M | 100.00% | LLY ×30.64 |
| Gross profit | $20.5B | 83.88% | $335M | 42.01% | LLY +41.9pp |
| Operating income | $8.6B | 35.28% | $130M | 16.30% | LLY +19.0pp |
| Pre-tax income | $8.4B | 34.46% | $71M | 8.92% | LLY +25.5pp |
| Net income | $6.5B | 26.44% | $70M | 8.74% | LLY +17.7pp |
| Stage | LLY | AMRX | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $796M100.00% | LLY ×30.64 |
| Gross profit | 83.88%$20.5B | 42.01%$335M | LLY +41.9pp |
| Operating income | 35.28%$8.6B | 16.30%$130M | LLY +19.0pp |
| Pre-tax income | 34.46%$8.4B | 8.92%$71M | LLY +25.5pp |
| Net income |
| 26.44%$6.5B |
| 8.74%$70M |
| LLY +17.7pp |
No shared counterparties.